Molecular Detection Gets USPTO OK for MRSA/MSSA MDx Patent

The company's test, called Detect-Ready, uses real-time PCR to amplify and evaluate multiple gene targets to detect and distinguish between samples containing MRSA, MSSA, and mixed populations of bacteria.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.